Annual report pursuant to Section 13 and 15(d)

Warrants

v3.22.1
Warrants
12 Months Ended
Mar. 31, 2022
Warrants  
Warrants

10. Warrants

The following is a continuity schedule of the Company’s common share purchase warrants:

    

    

Weighted 

Number of

Average

Warrants

Exercise Price

Outstanding and exercisable, March 31, 2020

 

125,034

 

20.07

Expired

 

(2,667)

 

(37.50)

Outstanding and exercisable, March 31, 2021

 

122,367

 

19.69

Expired

(42,684)

(9.38)

Outstanding and exercisable March 31, 2022

79,683

25.22

During the year ended March 31, 2022 and 2021, 42,684 and 2,667 warrants, respectively, expired in accordance with their terms.

The following is a summary of common share purchase warrants outstanding as of March 31, 2022.

Exercise

    

Number of

    

Price ($)

Warrants

Expiry Date

90.00

 

15,658

 

March 31, 2023

9.375

 

64,025

 

August 14, 2022

 

79,683

The weighted-average remaining contractual term of the outstanding warrants was 0.5 years.